Regeneron CEO: We want to retain efficacy and eliminate bad side effects with our cancer treatments

(7:6)

What does Regeneron Pharmaceuticals make?

(2:54)

A Great Place to Work and Live: Our Manufacturing Campuses in the Heart of New York’s Capital Region

(1:9)

Regeneron: The Path from Basic Research to Commercial Product

(2:2:44)

Regeneron’s Mission

(4:51)

🚨 Regeneron Pharmaceuticals faces a major setback as they lose their defense in a patent lawsuit.

(51)

Leonard S. Schleifer, MD, PHD, Founder, President \u0026 CEO, Regeneron Pharmaceuticals

(27:49)

Arvind Balasundaram of Regeneron: Unlocking Pharma's Data Secrets | Simulated Reality Podcast #44

(57:36)

Founder Stories: Founders of Regeneron, one of the world’s greatest drug developers

(2:2:44)

1년에 한번 오는 투자 기회, VRTX와 REGN 분석

(6:26)

Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer | Mad Money | CNBC

(6:48)

Discover Regeneron's Industrial Operations and Product Supply Campuses in Upstate New York

(2:29)

Pharmaron

(4:57)

The Employee Experience in Pre-Clinical Manufacturing and Process Development at Regeneron

(3:49)

Regeneron CEO Leonard Schleifer: Changing The Paradigm On Drug Access And Pricing | CNBC

(8:35)

How Regeneron Helps Employees Chart Their Own Career Path

(16:50)

Leonard S. Schleifer, M.D., Ph.D., Founder and Chief Executive Officer, Regeneron Pharmaceuticals

(41:42)

The Rise of Regeneron Pharmaceuticals: Exploring the Company's Success Factors and Stock Valuation

(8:51)

Regeneron Pharmaceuticals CEO: Changing Medicine | Mad Money | CNBC

(6:34)

Regeneron Pharmaceuticals - Quick Stock analysis

(18:42)

Winners \u0026 Losers: Las Vegas Sands, FMC Corp, Regeneron and Palantir

(1:7)

Life at Regeneron

(1:29)

Coach Declares the BMS Team is Now Celibate | Blue Mountain State

(4:37)

AstraZeneca CEO Soriot on Pharmaceuticals in China

(7:27)

What is Happening Inside the Republic of Gilead? (A Map Analysis)

(9:)

Discover Regeneron's Industrial Operations and Product Supply Campus in Raheen

(2:37)

Regeneron Pharmaceuticals REGN Q3 2024 Earnings Presentation

(1:1:55)

Meant for More: Unlocking the Future of Genetic Medicines

(57)

Regeneron CEO on the prospects for its eye drug Eylea

(3:29)

Regeneron, Sanofi Cut Heart Drug's Price to Spur Greater Use

(5:13)

2023 Year in Review: Our Focus on Genetic Medicines

(2:14)